The information system on treatment d emand in eu emcdda
This presentation is the property of its rightful owner.
Sponsored Links
1 / 30

The Information System on Treatment D emand in EU EMCDDA PowerPoint PPT Presentation


  • 53 Views
  • Uploaded on
  • Presentation posted in: General

The Information System on Treatment D emand in EU EMCDDA. Linda Montanari, Buenos Aires, 22-24 October 2003 CICAD/OAS, Demand Reduction Experts Group Meeting. Mission of the EMCDDA.

Download Presentation

The Information System on Treatment D emand in EU EMCDDA

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


The information system on treatment d emand in eu emcdda

The Information Systemon Treatment Demand in EUEMCDDA

Linda Montanari, Buenos Aires, 22-24 October 2003

CICAD/OAS, Demand Reduction Experts Group Meeting


Mission of the emcdda

Mission of the EMCDDA

  • To provide the Community and the EU Member States with objective, reliable and comparable information concerning drugs and drug addiction and their consequences 

  • Further information: http://www.emcdda.eu.int/


The information system on treatment d emand in eu emcdda

Tasks

Areas

Collecting and analysing existing data Improving data-comparison methods Disseminating data and information

Situation

Responses

Impact


Map of eu member states norway acceding and candidate countries

Map of EU Member States, Norway, acceding and candidate countries


S ituation analysis working methods

Situation analysis: Working methods

  • Key indicators

  • Core data and developing areas

  • Expert groups

  • Reporting guidelines

  • Analytical project groups


Key indicators a common language for describing the drug situation

Key indicatorsA common language for describing the drug situation

  • Extent and patterns of drug use in the general population

  • Prevalence of problem drug use

  • Drug-related deaths and mortality among drug users

  • Treatment demand

  • Drug-related infectious diseases


Core data and developing areas

Core data and developing areas

  • Crime

    • Arrest Data

    • Drug Related Crime

  • Drug Markets & Availability

    • Perceived availability

    • Seizures

    • Price & Purity

  • Social Exclusion

  • Youth and vulnerability

  • New Trends


Treatment demand indicator tdi

Treatment Demand IndicatorTDI

  • One of the 5 key Indicators at the EMCDDA

  • Provide information on the people demanding treatment in the specialised drug services in Europe

  • Further information:

  • http://www.emcdda.eu.int/situation/themes/demand_treatment.shtml


What is the o bjective

What is the objective?

  • To provide comparable, reliable and anonymous information on:

    • Number of people treated for their drug use

    • Characteristicsand Profile of clients

    • Patterns of use

    • Trends over time


What is the p urpose

What is the purpose?

  • Indirect indicator of trends in problem drug use

  • Identification of patterns of drug use

  • Basis for other methodologies on problemdrug useprevalence estimation

  • Identify patterns of use of services and plan and

    evaluation of services 


Which questions the tdi answer to

Information in TDI: 20 items

Which questions the TDI answer to?

What drug treatment?

  • Treatment contact details

    • centre type, time of treatment, source of referral

  • Socio-demographic information

    • gender, age, living and labour status, education, nationality

  • Drug related information

    • primary and secondary drug, substitution treatment, route of administration, frequency of use, age at first use

What characteristics of clients?

Which substances /

Patterns of use?


Guidelines

Guidelines

  • A joint EMCDDA/Pompidou Group protocol (TDI protocol), with definitions and guidelines for data collection

    TDI Protocol

    http://www.emcdda.org/multimedia/project_reports/situation/treatment_indicator_report.pdf


How data are collected

How data are collected?

  • 23 excel sheets (cross tabulations) inserted in a central EMCDDA database (EISDD)

  • By centre type: outpatient, inpatient, low threshold, GPs, prison, others

  • By each country (29):

    15 Member States

    + Norway

    + 10 acceding countries

    + 3 candidate countries


What are the main resources

What are the main resources?

  • Network: one expert identified in each country by the NFP

  • Working group in most of the countries involving professionals from the treatment centres at national level

  • European annual expert meeting: the state of progress and future perspectives

  • Small thematic working group (e.g. data coverage and cannabis data in 2003)


Some results clients admitted to drug treatment in 2001 trends and patterns of use

Some ResultsClients admitted to drug treatment in 2001:trends and patterns of use


Percent of new clients admitted to treatment by main drug in 2001

Percent of new clients admitted to treatmentby main drug in 2001

Source: 2002 Reitox National Reports; Standard Table 3; 2001 data

All Centre Types; N.cases: 34 768 (new clients)

Countries included: Dk, Ge, Gr, Sp, IR (2000 data), Nl, FI, Sw

Weighted average on the total numbers of new clients by country


Percent of new clients by main drug

Percent of new clients by main drug

Source: REITOX National Reports - Standard Table 3 –2001 data

(*) 2000 data – All centre types


The information system on treatment d emand in eu emcdda

% of new clients admitted to treatment for opiates, cocaine, cannnabis in some EU countries- 1996 to 2001 -

Source: Reitox National Reports; Standard Table 4; All Centre Types

Countries included: Dk, Ge, Gr, Sp, Nl, Sw

Average weighted on the number of clients by country


Percent of new outpatient clients in some country by source of referral

Percent of new outpatient clients in some country by source of referral

(n. 689)

(n. 488)

(n. 4700)

*

(n. 1258)

(n. 831)

(n. 5970)

Source: Reitox National Reports 2002 – TDI data -Outpatient Treatment Centres –

Valid per cent, n = 13 936 cases, new clients - * Ireland: 2000 data


Mean age of clients in treatment in 2001

  • Opiates and Cocaine between 20-29 and 30-39

  • Stimulants and cannabis between 15-19 and 20-29

Mean age of clients in treatment in 2001

New clientsAll clients

(n = 83571)(n.337842)

Denmark27.831.1

Germany24.026.8

Greece26.627.8

Spain29.331.5

Italy29.032.3

Luxembourg21.830.7

The Netherlands30.732.8

Finland22.925.5

Sweden31.031.8

United Kingdomn.a.28.3

Source: REITOX National Reports - Standard Table 3 – 2001 data

All centre types


Gender distribution among new clients in 2001

Gender distribution among new clientsin 2001

  • Mainly males: 79.2 males / 20.8 females

  • Differences between drugs:

    • Opiates:81.2 males / 18.8 females

    • Cocaine:85.0 males / 15.0 females

    • Stimulants:67.5 males / 32.5 females

    • Cannabis: 85.8 males / 14.2 females

  • Highest proportion of males in Spain (84.9), lowest in Sweden (69.1)

Source: Reitox National Reports -Outpatient Treatment Centres

N. Cases: n. 29 133

Countries: Dk, Ge, Gr, Sp, Nl, Fi, Sw


Percent of new outpatient clients by l evel of education in 2001

Percent of new outpatient clients by level of education in 2001

Source: Reitox National Reports 2002 – TDI data -Outpatient Treatment Centres

Valid per cent, n = 29 493 cases, new clients

Countries: Dk, Ge, Gr, Nl, Sp, Fin, Sw


Percent of new outpatient clients by l abour status among in 2001

Percent of new outpatient clients by labour status among in 2001

8.2% in general population

Source: Reitox National Reports 2002 – TDI data -Outpatient Treatment Centres

Valid per cent, n = 29 596 cases, new clients

Countries: Dk, Ge, Gr, Nl, Sp, Fin, Sw


Age at first use of main drug among new clients in some countries

Age at first use of main drug among new clients in some countries

Source: 2002 Reitox National Reports – Outpatient Treatment Centres

Year covered: 2001

Countries covered: Dk, Ge, Gr, Sp, Fin, Sw


Frequency of use of main drug new clients in 2001 l ast 30 days before starting treatment

Frequency of use of main drug:% new clients in 2001 (last 30 days before starting treatment)

%

Source: 2002 Reitox National Reports – TDI data – Outpatient Treatment Centres

Year covered: 2001

Countries covered: 2001: Dk, Ge, Gr, Nl, Fin, Sw


Route of administration among all and new clients in some country in 2001

Route of administration among all and new clients in some country in 2001

Source: Reitox National Reports 2002 – TDI data -Outpatient Treatment Centres

Countries: Dk, Ge, Gr, Ir (2000 data), Nl, Sp, Fin, Sw, Uk (all clients)


M ost used secondary drugs among new clients in 2001 in some countries

Most used secondary drugs among new clients in 2001 in some countries

85.1% use more than one drug

%

Source: Reitox National Reports 2002 – TDI data -Outpatient Treatment Centres

Valid per cent, n. 25 824 using a secondar drug (n =30 344 total new clients)

Countries: Dk, Ge, Gr, Nl, Sp, Fin, Sw


Conclusions 1

Conclusions (1)

  • Opiates main substance, followed by cannabis and cocaine

  • Decrease of opiates users, increase cannabis and cocaine

  • Clients are males in their 20s or 30s

  • Clients demand treatment spontaneously or through family

  • Social conditions are worsening than general population

  • Clients start to use in the adolescence: earlier for cannabis


Conclusions 2

Conclusions (2)

  • Polarization of frequency of use for opiates and cocaine graduation for stimulants and especially cannabis

  • Clients tend to inject opiates, sniff cocaine, eat stimulants: less injection among new clients

  • Polydrug use is apparent, with cannabis as main secondary drug, followed by cocaine

  • Relevant differences between countries


Further information on the 2003 eu drug situation

Further information on the 2003 EU drug situation:

  • http://annualreport.emcdda.eu.int/


  • Login